Global Ureteroscopes Market

Table of Content

1. Executive Summary

2. Market Research Methodology
2.1. Research methodology and design
2.2. Sample selection
2.3. Reliability and validity

3. Market Analysis
3.1. Market size and growth rates
3.2. Macroeconomic change
3.3. Market growth drivers, market dynamics and trends
3.4. Megatrends and their impact
3.5. Change and strategic drift
3.6. Characteristics mapping
3.7. Value chain analysis
3.8. Distribution platforms
3.9. Market scenarios and opportunity forecasts
3.10. Geographic analysis
3.11. Relevant markets
3.12. The new frontiers of growth
3.13. Creating value through sustainable strategies

4. Industry Analysis
4.1. Supply chain analysis
4.2. Fixing the supply chain
4.3. Upstream and downstream business opportunities
4.4. Porter’s five forces analysis
4.5. PEST analysis
4.6. Forecast factors
4.7. Technology roadmap
4.8. Cost structure analysis

5. COVID 19 Crisis Analysis
5.1. Statistics and probable future impact
5.2. Scenarios and path forward
5.3. Sector specific impact
5.4. Industry transformation
5.5. Action plan for industry players
5.6. Supply chain: actions to consider
5.7. Initiatives prioritization
5.8. Strategic crisis-action plan
5.9. The next normal
5.9.1. Supply chain
5.9.2. Regulations
5.9.3. Organizations

6. Market Breakdown by Product Type
6.1. Introduction
6.2. Flexible Ureteroscope
6.2.1. Fiberoptic Ureteroscope
6.2.2. Digital Ureteroscope
6.3. Semi-rigid Ureteroscope
6.4. Rigid Ureteroscope

7. Market Breakdown by Application
7.1. Introduction
7.2. Therapeutic Applications
7.2.1. Urolithiasis
7.2.2. Kidney Cancer
7.2.3. Ureteral Stinctures
7.2.4. Others
7.3. Diagnostic Applications

8. Market Breakdown by End-User
8.1. Introduction
8.2. Hospitals
8.3. Specialty Clinics
8.4. Ambulatory Surgical Centers
8.5. Diagnostic Imaging Centers

9. Market Breakdown by Geography
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Mexico
9.2.South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Russia
9.3.5. Italy
9.3.6. Spain
9.3.7. Sweden
9.3.8. Switzerland
9.3.9. Netherlands
9.3.10. Others
9.4. Asia
-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. South Korea
9.4.4. India
9.4.5. Singapore
9.4.6. Australia
9.4.7. Others
9.5.Middle East & Africa
9.5.1. South Africa
9.5.2. Saudi Arabia
9.5.3. UAE
9.5.4. Qatar
9.5.5. Israel
9.5.6. Others

10. Competitive Landscape
10.1. Low-cost position
10.2. Competitive situation and trends
10.3. Competitive strategies
10.4. Marketing strategies
10.5. Industry benchmarking
10.6. Maintaining current market share
10.7. Expansion path
10.8. Recent market and industry developments
10.8.1. New product developments and announcements
10.8.2. Agreements, partnerships, joint ventures, and collaborations
10.8.3. Mergers and acquisitions and major PE deals

11. Companies Profiled
11.1. Olympus Corporation
11.2. Boston Scientific Corporation
11.3. Stryker
11.4. Richard Wolf
11.5. Karl Storz SE & Co. KG
11.6. PENTAX Medical
11.7. Scholly Fiberoptic GmbH
11.8. ROCAMED, OPCOM Inc.
11.9. SOPRO-COMEG GmbH
11.10. Others

Request Sample

Buy Now